BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18332896)

  • 1. Assessment, diagnosis and treatment of a patient with hirsutism.
    Yildiz BO
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):294-300. PubMed ID: 18332896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.
    Gökmen O; Senöz S; Gülekli B; Işik AZ
    Gynecol Endocrinol; 1996 Aug; 10(4):249-55. PubMed ID: 8908525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diane 35 and spironolactone combination in the treatment of hirsutism.
    Kelestimur F
    Clin Endocrinol (Oxf); 2001 May; 54(5):699-700. PubMed ID: 11380503
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hirsutism].
    van Zuuren EJ; Pijl H
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
    Harborne L; Fleming R; Lyall H; Sattar N; Norman J
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4116-23. PubMed ID: 12970273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirsutism - from diagnosis to use of antiandrogens.
    Unluhizarci K; Karaca Z; Kelestimur F
    Front Horm Res; 2013; 40():103-14. PubMed ID: 24002408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
    Harmanci A; Cinar N; Bayraktar M; Yildiz BO
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):120-5. PubMed ID: 22702394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproterone acetate for hirsutism.
    Van der Spuy ZM; le Roux PA
    Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
    Kelekci KH; Kelekci S; Yengel I; Gul S; Yilmaz B
    J Dermatolog Treat; 2012 Jun; 23(3):177-83. PubMed ID: 21254871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of hirsutism].
    Ylöstalo P
    Duodecim; 1984; 100(11):686-90. PubMed ID: 6468307
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.
    Dahlgren E; Landin K; Krotkiewski M; Holm G; Janson PO
    Hum Reprod; 1998 Oct; 13(1O):2706-11. PubMed ID: 9804218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?
    Orio F; Palomba S; Cascella T; Tauchmanovà L; Di Biase S; Labella D; Russo T; Pellicano M; Savastano S; Zullo F; Lombardi G; Colao A
    J Endocrinol Invest; 2004 Jan; 27(1):61-6. PubMed ID: 15053246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiandrogen treatment of polycystic ovary syndrome.
    Rittmaster RS
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.